GLENMARK-A new way for a new world

New Drug Approvals


Traded asBSE532296NSEGLENMARK)
IndustryPharmaceuticalsDrugs &Healthcare
Founder(s)Gracias Saldanha
Key peopleGlenn Saldanha, MD & CEO [2]
ProductsMedicines and Vaccines
RevenueINR1031.10 crore(US$160 million) (2009–2010)[3]
Employees7,000 [4]
SubsidiariesGlenmark Generics Ltd[5]

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in MumbaiIndia[6] It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans segments such as DermatologyInternal MedicinePaediatricsGynaecologyENT andDiabetes.

It has four manufacturing facilities for formulations and additional three facilities for APIs. These manufacturing facilities are located in the states of MaharashtraGoaHimachal Pradesh and Gujarat in India.


View original post 1,595 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s